NAURA(SZ:002371) KAIYUAN SECURITIES·2025-09-01 01:59Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company's revenue growth trend remains robust despite a sequential decline in Q2 due to customer acceptance rhythm. The outlook for performance recovery in the second half of the year is positive [4][5] - In H1 2025, the company achieved operating revenue of 16.142 billion yuan, a year-on-year increase of 29.51%, driven by steady order growth [4] - The company continues to maintain high R&D investment, with R&D expenditure reaching 2.915 billion yuan in H1 2025, a year-on-year increase of 30.01% [4] Financial Performance Summary - In Q2 2025, the company reported revenue of 7.936 billion yuan, a year-on-year increase of 21.84% but a quarter-on-quarter decrease of 3.3% [5] - The net profit attributable to the parent company in Q2 was 1.627 billion yuan, a year-on-year decrease of 1.47% but a quarter-on-quarter increase of 2.95% [5] - The gross margin for Q2 was 41.29%, down 6.11 percentage points year-on-year and 1.73 percentage points quarter-on-quarter [5] Revenue and Profit Forecast - The company is expected to achieve operating revenues of 39.5 billion yuan, 48.8 billion yuan, and 59 billion yuan for the years 2025, 2026, and 2027 respectively [5] - The forecasted net profit attributable to the parent company is 7.84 billion yuan, 9.91 billion yuan, and 12.01 billion yuan for the same years [5] - The current stock price corresponds to P/E ratios of 34.3, 27.1, and 22.4 for the years 2025, 2026, and 2027 respectively [5] Market Position and Product Development - The company has established a comprehensive product matrix in the integrated circuit equipment sector, with significant revenue contributions from etching and thin film deposition equipment [6] - In H1 2025, the revenue from etching equipment exceeded 5 billion yuan, while thin film deposition equipment revenue surpassed 6.5 billion yuan [6] - The company is also expanding into the ion implantation equipment market and has launched several 12-inch ion implantation devices [6]